IGM Biosciences (IGMS) Hold Rating Reiterated at Needham & Company LLC theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Wedbush reiterated their outperform rating on shares of IGM Biosciences (NASDAQ:IGMS – Free Report) in a report published on Friday, RTT News reports. The brokerage currently has a $19.00 price target on the stock, down from their previous price target of $37.00. A number of other research firms have also recently commented on IGMS. Royal […]
IGM Biosciences (NASDAQ:IGMS – Get Free Report)‘s stock had its “hold” rating reaffirmed by stock analysts at Needham & Company LLC in a note issued to investors on Monday, Benzinga reports. IGMS has been the subject of several other reports. Guggenheim cut their price objective on shares of IGM Biosciences from $38.00 to $25.00 in […]
IGM Biosciences (NASDAQ:IGMS – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($1.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.40) by ($0.03), Briefing.com reports. IGM Biosciences had a negative net margin of 14,363.10% and a negative return on equity of 74.30%. The company had […]
IGM Biosciences (NASDAQ:IGMS – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($1.43) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.40) by ($0.03), Briefing.com reports. The firm had revenue of $0.45 million for the quarter, compared to analysts’ expectations of $0.80 million. IGM Biosciences had […]